# FDA Inspection 1095930 - Lotus Pharmaceutical Co., Ltd. - May 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/5f50c892-41ba-4efb-97fb-d8242acfe060
Source feed: FDA_Inspections

> FDA Inspection 1095930 for Lotus Pharmaceutical Co., Ltd. on May 31, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095930
- Company Name: Lotus Pharmaceutical Co., Ltd.
- Inspection Date: 2019-05-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1236763 - 2024-04-12](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/99a4af9e-28dc-44c1-a9cb-88210f19ecb4)
- [FDA Inspection 1028353 - 2017-09-22](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/c9a55bfd-d912-4152-91fb-6814241d953d)
- [FDA Inspection 933276 - 2015-06-04](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/d46a4b1a-1d95-4fec-ab9c-acb6b24fb450)
- [FDA Inspection 797095 - 2012-08-16](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/f38716a1-ac67-4580-b4bc-3b788a105fa7)
- [FDA Inspection 655757 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/2f880a9b-7f62-43bd-ae74-4a25420b8424)

Company: https://www.keypedia.com/companies/lotus-pharmaceutical-co-ltd/1043820e-dbbd-403f-b81f-fc75b7ed8ab7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c